Glenn J. Bubley

1990–2024 年に発表

61
論文数
19,095
被引用数
54
h 指数
61
i10 指数

被引用数

Glenn J. Bubley の年別被引用数1991 年: 被引用 2 件1992 年: 被引用 1 件1993 年: 被引用 5 件1994 年: 被引用 4 件1995 年: 被引用 7 件1996 年: 被引用 17 件1997 年: 被引用 18 件1998 年: 被引用 26 件1999 年: 被引用 31 件2000 年: 被引用 37 件2001 年: 被引用 79 件2002 年: 被引用 90 件2003 年: 被引用 125 件2004 年: 被引用 143 件2005 年: 被引用 128 件2006 年: 被引用 117 件2007 年: 被引用 118 件2008 年: 被引用 136 件2009 年: 被引用 153 件2010 年: 被引用 135 件2011 年: 被引用 182 件2012 年: 被引用 152 件2013 年: 被引用 215 件2014 年: 被引用 169 件2015 年: 被引用 153 件2016 年: 被引用 188 件2017 年: 被引用 209 件2018 年: 被引用 205 件2019 年: 被引用 551 件2020 年: 被引用 491 件2021 年: 被引用 540 件2022 年: 被引用 394 件2023 年: 被引用 247 件2024 年: 被引用 384 件2025 年: 被引用 139 件2026 年: 被引用 7 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,712 件、この内訳の 33.5%イギリス: 引用元論文 595 件、この内訳の 7.3%中国: 引用元論文 537 件、この内訳の 6.6%カナダ: 引用元論文 484 件、この内訳の 6%ドイツ: 引用元論文 361 件、この内訳の 4.5%イタリア: 引用元論文 336 件、この内訳の 4.1%フランス: 引用元論文 283 件、この内訳の 3.5%オーストラリア: 引用元論文 247 件、この内訳の 3.1%日本: 引用元論文 247 件、この内訳の 3.1%スペイン: 引用元論文 218 件、この内訳の 2.7%オランダ: 引用元論文 204 件、この内訳の 2.5%スイス: 引用元論文 172 件、この内訳の 2.1%
0%33.5%その他 21%

分野

  • Medicine66.7%
  • Biochemistry, Genetics and Molecular Biology25.1%
  • Immunology and Microbiology4.9%
  • Computer Science0.5%
  • Chemistry0.4%
  • Neuroscience0.4%
  • その他2%

トピック

  • Prostate Cancer Treatment and Research18.6%
  • Prostate Cancer Diagnosis and Treatment8.1%
  • Cancer, Lipids, and Metabolism4%
  • Hormonal and reproductive studies3%
  • Estrogen and related hormone effects2.5%
  • Radiopharmaceutical Chemistry and Applications2.4%
  • その他61.4%

共著者

全論文

検索で開く
  1. The Molecular Taxonomy of Primary Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fadi Brimo, Christopher A. Bristow, Denise Brooks, Bradley M. Broom, Alan H. Bryce, Glenn J. Bubley, Eric Burks, Yaron S.N. Butterfield, M. Button, David Canes, Carlos Gilberto Carlotti, Rebecca Carlsen, Michel Carmel, Peter R. Carroll, Scott L. Carter, Richard W. Cartun, Brett S. Carver, June M. Chan, Matthew T. Chang, Yu Chen, Andrew D. Cherniack, Simone Chevalier, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Sudha Chudamani, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Matthew R. Cooperberg, Niall M. Corcoran, Anthony J. Costello, Janet E. Cowan, Daniel Crain, Erin Curley, Kerstin A. David, John A. Demchok, Francesca Demichelis, Noreen Dhalla, Rajiv Dhir, Alexandre A. Doueik, Bettina F. Drake, Heidi Dvinge, Natalya Dyakova, Ina Felau, Martin L. Ferguson, Scott Frazer, Stephen J. Freedland, Yao Fu, Stacey Gabriel, Jianjiong Gao, Johanna Gardner, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Mark Gerstein, Gad Getz, Andrew K. Godwin, Anuradha Gopalan, Markus Graefen, Kiley Graim, Thomas Gribbin, Ranabir Guin, Manaswi Gupta, Angela Hadjipanayis, Syed Haider, Lucie Hamel, D. Neil Hayes, David I. Heiman ほか 212 名 - Cell 2015 被引用: 3,279

  2. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 2,241

  3. Biology of Prostate-Specific Antigen

    著者: , , - Journal of Clinical Oncology 2003 被引用: 714

  4. Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies

    著者: , , , , , , , , , , , , , , , - Cancer 2020 被引用: 112

  5. Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer

    著者: , , , , , , , - Cancer Research 2006 被引用: 1,076

  6. Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer

    著者: , , , , , , , - New England Journal of Medicine 1995 被引用: 1,253

  7. Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 165

  8. Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 61

  9. Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 281

  10. Neoadjuvant Enzalutamide Prior to Prostatectomy

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2016 被引用: 131

  11. Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 280

  12. Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 51

  13. Expanded Prostate Cancer Index Composite for Clinical Practice: Development and Validation of a Practical Health Related Quality of Life Instrument for Use in the Routine Clinical Care of Patients With Prostate Cancer

    著者: , , , , , , , , , , , , , , - The Journal of Urology 2011 被引用: 194

  14. Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - The Journal of Urology 2021 被引用: 77

  15. Taxane resistance in prostate cancer is mediated by decreased drug-target engagement

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 被引用: 53

  16. Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2024 被引用: 35

  17. Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

    著者: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 被引用: 31

  18. Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors

    著者: , , , , , , , , , , , - Cancer Research 2011 被引用: 424

  19. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.

    著者: , , , , , , , , - 2003 被引用: 304

  20. Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1

    著者: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 被引用: 203

  21. Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials

    著者: , , , , , , , , , , - The Journal of Urology 2021 被引用: 54

  22. FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with or without abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP).

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 27

  23. The idiopathic hypereosinophilic syndrome

    著者: , - Blood 1994 被引用: 943

  24. Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer

    著者: , , , , , , , - The Journal of Immunology 2001 被引用: 381